Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

By: Annenberg Center for Health Sciences
  • Summary

  • In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.
    Annenberg Center for Health Sciences
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Cardiologist Collaboration
    Mar 5 2024
    • Role in Diabetes Management
    • Multidisciplinary Team-based Approach
    Show More Show Less
    5 mins
  • Individualizing Therapy
    Mar 5 2024
    • Drug Initiation and Monitoring
    • Contraindications and Adverse Effects
    • Patient Education
    Show More Show Less
    8 mins
  • Cardiovascular Benefits
    Mar 5 2024
    • FDA Indications
    • Clinical Trial Evidence

    Show More Show Less
    4 mins

What listeners say about Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.